Advance Market Analytics published a new research publication on “Medical Cannabis Market Insights, to 2027” with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Medical Cannabis market was mainly driven by the increasing R&D spending across the world. According to AMA, the Global Medical Cannabis market is expected to see growth rate of 24.5%.
Some of the key players profiled in the study are:
BOL Pharma (Israel), Tilray (Canada), Medreleaf Corporation (Canada), Aurora Cannabis, Inc. (Canada) , Canopy Growth Corporation (Canada), Insys Therapeutics, Inc. (United States), Aphria, Inc. (Canada), MGC Pharmaceuticals Limited (Australia), GW Pharmaceuticals, plc (United Kingdom), Medical Marijuana Inc. (United States).
Get Free Exclusive PDF Sample Copy of This Research @ https://www.advancemarketanalytics.com/sample-report/1757-global-medical-cannabis-market
Scope of the Report of Medical Cannabis
Medicinal cannabis is also known as Medical marijuana, which is used either to treat disease or to improve their symptoms. The two cannabinoids such as delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in the treatment of a certain disease or health conditions such as pain, memory, blood pressure, concentration, appetite, sensory stimulus, muscular problems, and seizures. The numerous economies are involved in the activities to legalize the export of medicinal cannabis product, which in turn is expected to fuel the growth of the medical cannabis market.
Market Leaders and some development strategies
On 22 Jan 2019, Tilray, Inc. has announced a definitive agreement with Natura Naturals Holdings Inc., the parent company of a licensed cultivator of cannabis. Due to the agreement, Tilray will obtain Natura’s 662,000 square-foot greenhouse cultivation facility, of which 155,000 square-feet are currently licensed, and all subsequent cannabis output from this facility. and On 19 March 2018, MedReleaf Corp., Canada’s first and only ISO 9001 and ICH-GMP certified cannabis producer, has announced that it has entered into an agreement to become the largest supplier of medical cannabis products to Cannamedical Pharma GMBH, a leading medical cannabis distributor to pharmacies in Germany.
On 21 Jan. 2019, Canopy Growth Corporation has announced the expansion of its business in the European regions such as the United Kingdom and Poland where its medically-focused business Spectrum Cannabis continues to build a sophisticated, pan-European cannabis production as well as distribution network serving the needs of physicians and their patients throughout the continent.
On 9 Oct. 2018, Canopy Growth Corporation has completed a legal transfer of cannabis products to a research partner in the United States. This transfer is the initial export of legal cannabis products from Canada to the United States pursuant to an import permit issued by the federal United States Drug Enforcement Administration.
On January 16, 2019, California’s three state cannabis licensing authorities have announced that the Office of Administrative Law (OAL) officially approved state regulations for cannabis businesses across the supply chain.
The titled segments and sub-section of the market are illuminated below:
by Active Ingredients (Tetrahydrocannabinol {THC}, Cannabidiol {CBD}), Point of Sale (Dispensaries, Online Pharmacy, Hospital Pharmacy), Therapeutic Application (Pain, Arthritis, Neurological Disease {Epilepsy, Multiple Sclerosis, and Other Neurological Applications}, Other)
Market Trends:
The launch of New Cannabis Consumer Products
Transition to Adult-Use Cannabis
Health Safety in Cannabis Products
Opportunities:
Emerging Demand From Economies
Market Drivers:
Expansion Of Medicinal Cannabis Product By Various Manufacturers
Legalization Of Medicinal Cannabis In Various Economies
Rising geriatric population in need of treatment for chronic diseases
Increasing Research And Development Activities
Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa
Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.
Have Any Questions Regarding Global Medical Cannabis Market Report, Ask Our [email protected] https://www.advancemarketanalytics.com/enquiry-before-buy/1757-global-medical-cannabis-market
Strategic Points Covered in Table of Content of Global Medical Cannabis Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Medical Cannabis market
Chapter 2: Exclusive Summary – the basic information of the Medical Cannabis Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Medical Cannabis
Chapter 4: Presenting the Medical Cannabis Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country 2015-2020
Chapter 6: Evaluating the leading manufacturers of the Medical Cannabis market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2021-2027)
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
finally, Medical Cannabis Market is a valuable source of guidance for individuals and companies.
Read Detailed Index of full Research Study at @ https://www.advancemarketanalytics.com/reports/1757-global-medical-cannabis-market
Contact Us:
Craig Francis (PR & Marketing Manager)
AMA Research & Media LLP
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
[email protected]
Connect with us at
https://www.linkedin.com/company/advance-market-analytics
https://www.facebook.com/AMA-Research-Media-LLP-344722399585916
https://twitter.com/amareport
Recent Comments